Brain Tumor Res Treat.  2019 Oct;7(2):105-111. 10.14791/btrt.2019.7.e39.

Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies

Affiliations
  • 1Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea. nschpark@snu.ac.kr
  • 2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Only sporadic reports of fluorescence-guided surgery (FGS) have been published for non-glioma conditions. In this study, we focus on epidemiological data of fluorescence patterns and report the diverse experiences of FGS in non-gliomas.
METHODS
During 8.5 years between July 2010 and January 2019, 900 FGS for brain tumor performed in Seoul National University Hospital. Among them, a total of 73 histologically proven non-glioma patients were analyzed. Indications for FGS have been the possibility of anaplastic tumor in intra-axial tumors in preoperative MRI and an attempt to reproduce known anecdotal experiences of 5-Aminolevulinic Acid (5-ALA) fluorescence.
RESULTS
In cases of brain tumors except for gliomas, the most frequent cases were brain metastasis (23 cases) followed by lymphomas (9 cases) and meningeal tumors (8 cases). And there were embryonal tumors (6 cases), hemangioblastomas (4 cases), and solitary fibrous tumor/hemangiopericytomas (3 cases). Most brain metastases, meningiomas, primary central nervous system lymphomas, and treatment effect cases showed positive fluorescence. Moreover, some non-tumorous conditions also showed positive fluorescence. However, hemangioblastoma and germ cell tumor did not observe any fluorescence at all.
CONCLUSION
5-ALA induced fluorescence is not limited to glioma but is also evident in non-glioma and non-neoplastic conditions. This 5-ALA-induced fluorescence may be used as an intraoperative tool for various brain conditions.

Keyword

Fluorescence; Surgery; Meningioma; Metastasis

MeSH Terms

Brain
Brain Neoplasms
Central Nervous System
Fluorescence
Glioma
Hemangioblastoma
Humans
Lymphoma
Magnetic Resonance Imaging
Meningeal Neoplasms
Meningioma
Neoplasm Metastasis
Neoplasms, Germ Cell and Embryonal
Pathology*
Seoul

Figure

  • Fig. 1 Distribution of histological diagnosis of 73 fluorescence-guided surgery cases excluding glioma. Experience of 827 glioma cases is described in the other paper in this issue (Experience profiling of fluorescence-guided surgery I: gliomas). Numbers in the diagram indicate number of cases. SFT/HPC, solitary fibrous tumor/hemangiopericytoma; Gr, grade.

  • Fig. 2 A: Distribution of fluorescence intensity of 23 brain metastasis from various primary cancer sites. A single cubic unit denotes individual case. B: Illustrative case of brain metastasis of malignant peripheral nerve sheath tumor (MPNST). Transaxial T2-weighted and coronal T1-weighted MR images show a well enhancing round-shpaed mass with internal hemorrhage and peritumoral edema in left temporal lobe. The mass was excised in en bloc fashion and the part of the internal side of the mass showed strong red fluorescence. RCC, renal cell carcinoma.

  • Fig. 3 Intraoperative photograph showing positive fluorescence and magnetic resonance images of 3 primary central nervous system angiitis cases.

  • Fig. 4 Magenetic resonance images and intraoperative fluorescence pattern of treatment effect after radiotherapy. Positive fluorescence areas were observed although no viable tumor cells were idendtified in histological examination.

  • Fig. 5 Examples of non-tumorous conditions showing positive fluorescenase. A: A case of intracranial heterotopic ossification. Non-contrast computed tomography shows dense calcific lesion in the left frontal lobe.The lesion is irregulary enhanced in MRI. Intraoperative finding shows strong fluorescence. Histologically, the mass is composed of calcification with numerous Rosenthal fibers. B: A case of glioependymal cyst. Preoperative MRI shows an enhanced mass lesion with cyst in the left periventricular white matter. The solid portion of resected mass exhibit strong fluorescence. Histological finding denies any evidence of neoplasm but for only showing reactive gliosis with ciliated ependymal linings. A, B: Hematoxylin and eosin stain; original magnification ×400. C: Cases of pachymeningitis (left) and meningoencephlitis (right) which shows positive fluorescence.


Reference

1. Hadjipanayis CG, Widhalm G, Stummer W. What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery. 2015; 77:663–673.
Article
2. Ewelt C, Nemes A, Senner V, et al. Fluorescence in neurosurgery: Its diagnostic and therapeutic use. Review of the literature. J Photochem Photobiol B. 2015; 148:302–309.
Article
3. Chae MP, Song SW, Park SH, Park CK. Experience with 5-aminolevulinic acid in fluorescence-guided resection of a deep sylvian meningioma. J Korean Neurosurg Soc. 2012; 52:558–560.
Article
4. Valdes PA, Bekelis K, Harris BT, et al. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo. Neurosurgery. 2014; 10 Suppl 1:74–82.
Article
5. Grimbergen MC, van Swol CF, van Moorselaar RJ, Uff J, Mahadevan-Jansen A, Stone N. Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid. J Photochem Photobiol B. 2009; 95:170–176.
Article
6. Huber RM, Gamarra F, Hautmann H, et al. 5-aminolaevulinic acid (ALA) for the fluorescence detection of bronchial tumors. Diagn Ther Endosc. 1999; 5:113–118.
Article
7. Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M. Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest. 2006; 129:718–724.
Article
8. Millesi M, Kiesel B, Woehrer A, et al. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors. Neurosurg Focus. 2014; 36:E11.
Article
9. Kamp MA, Munoz-Bendix C, Mijderwijk HJ, et al. Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival. J Neurooncol. 2019; 141:547–553.
Article
10. Utsuki S, Miyoshi N, Oka H, et al. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol. 2007; 24:53–55.
Article
11. Kamp MA, Grosser P, Felsberg J, et al. 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien). 2012; 154:223–228.
Article
12. Marbacher S, Klinger E, Schwyzer L, et al. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus. 2014; 36:E10.
Article
13. Kamp MA, Fischer I, Bühner J, et al. 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget. 2016; 7:66776–66789.
Article
14. Teng L, Nakada M, Zhao SG, et al. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer. 2011; 104:798–807.
Article
15. Utsuki S, Oka H, Sato S, et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo). 2007; 47:210–213.
Article
16. Valdes PA, Millesi M, Widhalm G, Roberts DW. 5-aminolevulinic acid induced protoporphyrin IX (ALA-PpIX) fluorescence guidance in meningioma surgery. J Neurooncol. 2019; 141:555–565.
Article
17. Potapov AA, Goryaynov SA, Okhlopkov VA, et al. Laser biospectroscopy and 5-ALA fluorescence navigation as a helpful tool in the meningioma resection. Neurosurg Rev. 2016; 39:437–447.
Article
18. Morofuji Y, Matsuo T, Hayashi Y, Suyama K, Nagata I. Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery. 2008; 62:3 Suppl 1. 102–103.
19. Kajimoto Y, Kuroiwa T, Miyatake S, et al. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. J Neurosurg. 2007; 106:1070–1074.
Article
20. Coluccia D, Fandino J, Fujioka M, Cordovi S, Muroi C, Landolt H. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir (Wien). 2010; 152:1711–1719.
Article
21. Cornelius JF, Slotty PJ, Kamp MA, Schneiderhan TM, Steiger HJ, El-Khatib M. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors. Photodiagnosis Photodyn Ther. 2014; 11:481–490.
Article
22. Foster N, Eljamel S. ALA-induced fluorescence image guided surgery of meningiomas: a meta-analyses. Photodiagnosis Photodyn Ther. 2016; 15:73–78.
Article
23. Millesi M, Kiesel B, Mischkulnig M, et al. Analysis of the surgical benefits of 5-ALA-induced fluorescence in intracranial meningiomas: experience in 204 meningiomas. J Neurosurg. 2016; 125:1408–1419.
Article
24. Della Puppa A, Rustemi O, Gioffrè G, et al. Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery. J Neurosurg. 2014; 120:840–845.
Article
25. Valdés PA, Leblond F, Kim A, et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg. 2011; 115:11–17.
Article
26. Yamamoto J, Kitagawa T, Akiba D, Nishizawa S. 5-Aminolevulinic acid-induced fluorescence in cerebellar primary central nervous system lymphoma: a case report and literature review. Turk Neurosurg. 2015; 25:796–800.
Article
27. Kiesel B, Millesi M, Woehrer A, et al. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. Neurosurg Focus. 2018; 44:E7.
Article
28. Takada T, Tamura M, Yamamoto T, Matsui H, Matsumura A. Selective accumulation of hematoporphyrin derivative in glioma through proton-coupled folate transporter SLC46A1. J Clin Biochem Nutr. 2014; 54:26–30.
Article
29. Desmoulin SK, Hou Z, Gangjee A, Matherly LH. The human protoncoupled folate transporter: Biology and therapeutic applications to cancer. Cancer Biol Ther. 2012; 13:1355–1373.
30. Evers G, Kamp M, Warneke N, et al. 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma. World Neurosurg. 2017; 98:375–380.
Article
31. El-Sharabasy MM, el-Waseef AM, Hafez MM, Salim SA. Porphyrin metabolism in some malignant diseases. Br J Cancer. 1992; 65:409–412.
Article
32. Rittenhouse-Diakun K, Van Leengoed H, Morgan J, et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol. 1995; 61:523–528.
Article
33. Yamamoto T, Ishikawa E, Miki S, et al. Photodynamic diagnosis using 5-aminolevulinic acid in 41 biopsies for primary central nervous system lymphoma. Photochem Photobiol. 2015; 91:1452–1457.
Article
34. Utsuki S, Oka H, Kijima C, Miyajima Y, Hagiwara H, Fujii K. Utility of intraoperative fluorescent diagnosis of residual hemangioblastoma using 5-aminolevulinic acid. Neurol India. 2011; 59:612–615.
Article
35. Utsuki S, Oka H, Sato K, Shimizu S, Suzuki S, Fujii K. Fluorescence diagnosis of tumor cells in hemangioblastoma cysts with 5-aminolevulinic acid. J Neurosurg. 2010; 112:130–132.
Article
36. Takeda J, Nonaka M, Li Y, et al. 5-ALA fluorescence-guided endoscopic surgery for mixed germ cell tumors. J Neurooncol. 2017; 134:119–124.
Article
37. Kamp MA, Felsberg J, Sadat H, et al. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy. Acta Neurochir (Wien). 2015; 157:207–213.
Article
38. Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurologist. 2003; 9:180–188.
Article
39. Chaskis C, Neyns B, Michotte A, De Ridder M, Everaert H. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol. 2009; 72:423–428.
Article
40. Brandes AA, Tosoni A, Spagnolli F, et al. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol. 2008; 10:361–367.
Article
41. De Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology. 2004; 63:535–537.
Article
42. Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. Mol Interv. 2004; 4:273–284.
Article
43. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008; 9:453–461.
Article
44. Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery. 2009; 65:1070–1076.
Article
45. Behling F, Hennersdorf F, Bornemann A, Tatagiba M, Skardelly M. 5-Aminolevulinic acid accumulation in a cerebral infarction mimicking high-grade glioma. World Neurosurg. 2016; 92:586.e5–586.e8.
Article
46. Nestler U, Warter A, Cabre P, Manzo N. A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence. Acta Neurochir (Wien). 2012; 154:899–901.
Article
47. Höhne J, Brawanski A, Schebesch KM. Fluorescein sodium-guided surgery of a brain abscess: a case report. Surg Neurol Int. 2016; 7(Suppl 39):S955–S957.
Article
48. Omoto K, Matsuda R, Nakagawa I, Motoyama Y, Nakase H. False-positive inflammatory change mimicking glioblastoma multiforme under 5-aminolevulinic acid-guided surgery: a case report. Surg Neurol Int. 2018; 9:49.
Article
Full Text Links
  • BTRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr